Value of shear wave elastography in evaluating response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.

J Int Med ResSep 3, 2026 (epub)

Bin Lian, Chuanxin Ye, Fengjie Li et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the effectiveness of shear wave elastography in assessing the pathological response to neoadjuvant chemotherapy in breast cancer patients. Analyzing data from 15 trials involving 1402 patients, the study found a pooled sensitivity of 0.68 and specificity of 0.73, indicating moderate diagnostic performance with an area under the curve of 0.85.

Key findings

  • Pooled sensitivity of shear wave elastography was 0.68 (95% CI: 0.49-0.86).
  • Pooled specificity was 0.73 (95% CI: 0.60-0.87).
  • The pooled diagnostic odds ratio was 13.06 (95% CI: 8.42-20.25).
  • The area under the curve for diagnostic performance was 0.85 (95% CI: 0.82-0.88).

Why it matters

Understanding the diagnostic performance of shear wave elastography can aid clinicians in monitoring treatment responses in breast cancer, potentially improving patient management and outcomes during neoadjuvant chemotherapy.

Source

Published in J Int Med Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.